“Good Cholesterol” Helps Diabetics Heal

In the Media

Good cholesterol could help protect diabetics from heart disease complications and limb amputations that impact the lives of thousands of Australians each year, new research has revealed.

A newly-published study by the Heart Research Institute in Sydney has found for the first time that high-density lipoprotein (HDL) cholesterol, which is believed to help guard against heart disease, may also stimulate new blood vessel growth in people with diabetes.

“Diabetics have reduced ability to form new blood vessels, putting them at risk of life threatening vascular complications, so to be able to find a potential solution to this problem is very exciting,” says HRI researcher Dr Christina Bursill.

“With this discovery we have possible new therapies that could spare them the life-threatening complications and debilitating amputations that many people with diabetes will face.”

The findings are published today in the international journal Diabetes.

About 920,000 adult Australians live with diabetes, a disease where your body cannot control its blood sugar levels properly, either because the body doesn’t produce insulin or has become resistant to it.[1] Diabetics have difficulty in forming new blood vessels that are essential for wound healing and for tissue regeneration following a heart attack.

“As a result they don’t recover quickly from complications associated with impaired healing and are more likely to have limbs amputated or have a higher risk of having a heart attack,” explains Dr Bursill.

“There have been significant advances in treatment of vascular diseases but sadly 20-30 percent of these patients do not respond well to current therapies and this is largely due to complications associated with diabetes. New treatments for diabetics are desperately needed.”[2]

The HRI’s Immunobiology Group has previously discovered that HDL can promote new blood vessel formation in healthy bodies. In the new study the team set out to investigate whether good cholesterol could also increase blood vessel formation in diabetics, where the stimulation of new blood vessels is really needed.

They tested the hypothesis in the laboratory to see the effects of HDL on a wound and a vessel blockage in the leg similar to those experienced by diabetics. Using laser imaging and tissue analysis, researchers were able to check for new blood vessel growth.

“We found that HDL, whether delivered intravenously or by local application onto a wound, restored new blood vessel formation to levels seen in healthy models,” Dr Bursill says. “This led to increased blood flow in the leg and accelerated wound closure.”

The study also investigated the intracellular mechanisms of how exactly HDL rescues impaired new blood vessel formation in diabetes, which may lead to future development of novel therapeutic agents, the researcher say.

Associate Professor Martin Ng from the Heart Research Institute and co-author said, “These findings also highlight a new pathway for the translation of HDL, which until now, has been focussed on reducing advanced plaque formation in the vessels of the heart”.

The Heart Research Institute now hopes to take the work into a clinical setting, firstly to determine if topical infusions of HDL can improve wound repair and healing in diabetic patients with non-healing wounds or ulcers.

“We will also delve into the mechanisms underlying these effects further to identify future therapeutic targets,” he says.

The paper, entitled High Density Lipoproteins Rescue Diabetes-Impaired Angiogenesis via Scavenger Receptor Class B Type I, is published in the journal Diabetes.


[1] Australian Bureau of Statistics 2011–12 Australian Health Survey: http://www.aihw.gov.au/how-common-is-diabetes

[2] Abaci et al. (1999) Circulation 99:2239.

This ran as an exclusive story on 9 News, August 25, 6:40 pm


Related news

Crystal ball molecule predicts diabetes before it strikes

HRI researchers have developed a simple test to predict diabetes more than a decade before it strikes, a breakthrough that could help ease the impending diabetes epidemic. The team has uncovered an important molecule found in liver fat that can identify who is most at risk of developing diabetes and other cardio-metabolic disorders like liver disease.  

Read more

New drug hope to target silent killer

An exciting new treatment for very high blood pressure is on the horizon after a world-first discovery by Heart Research Institute scientists, who have uncovered a brain chemical instrumental in triggering hypertension, the so-called silent killer responsible for the deaths of thousands of Australians each year.

The researchers are optimistic the results, published this week in the American Journal of Physiology-Heart and Circulatory Physiology, will ultimately lead to a powerful new treatment that blocks a neurotransmitter and frees patients from the dangers of hypertension. 

Read more

Gout drug mends broken hearts

A drug used to treat arthritis has been found to clear clogged arteries in heart attack survivors, world-first Australian research shows.

The landmark discovery by Associate Professor Sanjay Patel, Leader of the Cell Therapeutics Group, and his team at the HRI paves the way for a cheap, simple and effective treatment regime that could protect thousands of Australian heart patients from future attacks that might kill them or further damage their heart. 

Read more